Plain-English translation of NCT05700058 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a leucine-enriched whey protein supplement called "super-whey" to see which dose works best at helping older adults build muscle. Researchers know that as people age, their muscles don't respond as well to protein and exercise—a problem called anabolic resistance. This study will compare three small doses of the medication to find the one that most effectively triggers muscle building.
As people get older, they naturally lose muscle mass, which can make daily activities harder and affect overall health. The medication being tested is designed to be low-dose and easy to tolerate, so it could help older adults maintain muscle without making them feel too full—a common problem with regular protein supplements.
You likely qualify if…
You likely don't qualify if…
You would attend study visits where you'll consume one of three doses of the protein supplement and then perform light exercise. Researchers will measure how well your muscles respond by taking muscle samples and tracking protein synthesis. The study compares how your body reacts to each dose to determine which one works best, with visits likely involving exercise and blood or tissue sampling.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United Kingdom